Canadian Treat and Extend Analysis Trial With Ranibizumab
Clinical trial NCT02103738 · COMPLETED
Trial details
- NCT number
- NCT02103738
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-05-08
- Primary completion
- 2019-07-31
- Enrollment
- 505
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.